Aurobindo Pharma Sees Significant Open Interest Surge Amid Mixed Market Dynamics
Aurobindo Pharma Ltd. has seen a notable rise in open interest, reaching 49,751 contracts, alongside a trading volume of 35,207 contracts. Despite a slight decline in price performance compared to its sector, the stock maintains adequate liquidity for trading, indicating active market engagement and shifting dynamics.
Aurobindo Pharma Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant increase in open interest today. The latest open interest stands at 49,751 contracts, reflecting a rise of 5,789 contracts or 13.17% from the previous open interest of 43,962. This uptick comes alongside a trading volume of 35,207 contracts, indicating active market participation.In terms of price performance, Aurobindo Pharma has underperformed its sector, recording a 1D return of -0.80%, while the sector itself saw a modest gain of 0.37%. The stock is currently trading at an underlying value of Rs 1,186. Notably, the stock's moving averages show it is above the 50-day and 100-day averages but below the 5-day, 20-day, and 200-day averages, suggesting mixed momentum.
Additionally, the stock has seen a decline in investor participation, with delivery volume dropping by 66.07% compared to the 5-day average. Despite this, Aurobindo Pharma maintains sufficient liquidity for trades sized at Rs 2.15 crore, based on 2% of the 5-day average traded value. Overall, the notable increase in open interest highlights a shift in market dynamics for Aurobindo Pharma, warranting attention from market observers.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
